Yüklüyor......
Clinical trial of sparfloxacin for lepromatous leprosy.
Nine previously untreated patients with lepromatous leprosy were treated with 200 mg of sparfloxacin daily for 12 weeks to determine whether this drug is bactericidal for Mycobacterium leprae in humans. The efficacy of therapy was monitored both clinically and by measuring changes in morphological i...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC284397/ https://ncbi.nlm.nih.gov/pubmed/8141581 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|